RGS: has a mention on The Australian Top 100 picks for 2014
by: Tim Blue From: The Australian December 28, 2013 12:00AM
I copied this from RGS thread. thanks to Oilyman
61 Regeneus (RGS)
A REGENERATIVE medicine company that is commercialising cell-based therapies for treating conditions such as arthritis in humans and animals. BBY suggests it is well placed to benefit from legislation passed by Japan's Upper House in early December that allows fast-track approval of stem cell therapies. The new legislation opens the way for RGS to launch an off-the-shelf human stem-cell therapy for osteoarthritis in Japan within three to four years, if it can demonstrate safety and efficacy in clinical trials. BBY has it as a spec buy with a target price of 76c a share.
- Forums
- ASX - Day Trading
- daytrading dec 30 pre-market
daytrading dec 30 pre-market, page-105
-
- There are more pages in this discussion • 181 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)